Familial hypercholesterolemia. A genetic regulatory defect in cholesterol metabolism.
暂无分享,去创建一个
[1] M. Brown,et al. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.
[2] M. Brown,et al. Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[3] K. Ak,et al. Cholesterol synthesis by cultured fibroblasts: decreased feedback inhibition in familial hypercholesterolemia. , 1974 .
[4] Marvin D. Siperstein,et al. Regulation of cholesterol biosynthesis in normal and malignant tissues. , 1970 .
[5] S. Grundy,et al. An evaluation of four methods for measuring cholesterol absorption by the intestine in man. , 1971, Journal of lipid research.
[6] J. Avigan,et al. In vitro effects of serum proteins and lipids on lipid synthesis in human skin fibroblasts and leukocytes grown in culture. , 1972, Biochimica et biophysica acta.
[7] M. Brown,et al. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[8] N. Myant,et al. Studies in the metabolism of cholesterol in subjects with normal plasma cholesterol levels and in patients with essential hypercholesterolaemia. , 1967, Clinical science.
[9] Joseph L. Goldstein,et al. Familial hypercholesterolemia: Defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity , 1974, Proceedings of the National Academy of Sciences.
[10] M. Brown,et al. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.
[11] M. Brown,et al. Homozygous familial hypercholesterolemia: specificity of the biochemical defect in cultured cells and feasibility of prenatal detection. , 1974, American journal of human genetics.
[12] R. Levy,et al. The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. , 1972, The Journal of clinical investigation.
[13] N. Nevin,et al. Hyperlipidaemic xanthomatosis. II. Mode of inheritance in 55 families with essential hyperlipidaemia and xanthomatosis. , 1968, Journal of medical genetics.
[14] A. Motulsky,et al. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. , 1973, The Journal of clinical investigation.
[15] S. Grundy,et al. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. , 1971, The Journal of laboratory and clinical medicine.
[16] A. Khachadurian. THE INHERITANCE OF ESSENTIAL FAMILIAL HYPERCHOLESTEROLEMIA. , 1964, The American journal of medicine.
[17] J. Goldstein,et al. Expression of the Familial Hypercholesterolemia Gene in Heterozygotes: Mechanism for a Dominant Disorder in Man , 1974, Science.
[18] M. Brown,et al. Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol. , 1974, The Journal of biological chemistry.